SLDB
Solid Biosciences LLC
8.90$
+0.5%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -27.0% | +87.5% | +83.2% | -25.9% | +65.4% | +35.8% | +12.0% | -36.6% | +14.4% | +23.3% | |
| – | -28.2% | +76.8% | +82.1% | -32.9% | +84.1% | +40.1% | -1.3% | -40.9% | +21.2% | +30.6% | |
| – | -73.1% | +578.3% | +65.8% | -12.0% | +103.5% | -23.0% | +30.4% | -52.4% | +8.4% | -25.3% | |
| – | -32.0% | +83.5% | +77.2% | -31.8% | +85.3% | +34.3% | +2.9% | -42.1% | +20.4% | +26.1% | |
| – | – | – | – | – | – | – | -100.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +437.4% | +329.1% | +59.6% | -29.5% | -44.9% | +49.4% | – | – | – | |
| – | +3.8% | +72.5% | -89.4% | +62.5% | +66.9% | -38.2% | +101.0% | -20.8% | +33.7% | +2.2% | |
| – | -50.6% | +64.0% | +10.7% | +46.4% | +33.9% | -3.6% | -4.6% | -35.5% | +108.4% | +10.6% | |
| – | – | – | – | +1,011.0% | +14.8% | -32.3% | +71.6% | -9.4% | +29.9% | -30.3% | |
| – | +390.8% | +69.8% | -27.1% | +93.0% | -54.0% | +36.3% | -27.4% | -37.2% | +108.5% | -23.9% | |
| – | – | – | – | -36.1% | +65.0% | +57.6% | +1.7% | -40.2% | +8.5% | +31.2% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +67.6% | +3.2% | +21.1% | +28.9% | +105.6% | +19.6% | +133.6% | +105.3% | +114.4% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.